Jazz Pharmaceuticals
JAZZ
#1899
Rank
S$13.36 B
Marketcap
S$219.91
Share price
1.67%
Change (1 day)
33.76%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -S$0.89 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$4.15 Billion. In 2024 the company made an earning of S$0.60 Billion, an increase over its 2023 earnings that were of S$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.89 Billion-245.93%
2024 S$0.60 B57.87%
2023 S$0.38 B-179.92%
2022 -S$0.49 Billion230.37%
2021 -S$0.15 Billion-141.02%
2020 S$0.35 B-39.45%
2019 S$0.58 B-14.2%
2018 S$0.68 B20.03%
2017 S$0.57 B-17.15%
2016 S$0.68 B22.14%
2015 S$0.56 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.39 B73.63%
2012 S$0.22 B41.69%
2011 S$0.16 B116.61%
2010 S$74.88 M262.77%
2009 S$20.64 M-111.33%
2008 -S$0.19 Billion1.31%
2007 -S$0.18 Billion77.8%
2006 -S$0.11 Billion36.59%
2005 -S$74.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Endo International
ENDPQ
-S$3.1 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
S$2.71 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.27 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
S$2.29 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel